Hospital-level Variation in Utilization of Surgery for Clinical Stage I-II Pancreatic Adenocarcinoma

Annals of Surgery

Volumn 269, Issue 1, 2019, Pages 133-142

  Swords, Douglas S ^a,b   Mulvihill, Sean J ^a   Skarda, David E ^b   Finlayson, Samuel R G ^a   Stoddard, Gregory J ^a   Ott, Mark J ^b   Firpo, Matthew A ^a   Scaife, Courtney L ^a  

^a UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^b INTERMOUNTAIN HEALTHCARE   (United States)

Author keywords

hospital; pancreatic adenocarcinoma; pancreatic cancer; pancreatic ductal adenocarcinoma; rate; surgery; survival; underutilization; utilization; variation

Indexed keywords

ANTINEOPLASTIC AGENT;

ADULT; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER DIAGNOSIS; CANCER LOCALIZATION; CANCER MORTALITY; CANCER REGISTRY; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; COHORT ANALYSIS; CONTROLLED STUDY; FEMALE; HEALTH CARE UTILIZATION; HEALTH INSURANCE; HOSPITAL CHARGE; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICARE; OVERALL SURVIVAL; PANCREAS ADENOCARCINOMA; PRIORITY JOURNAL; RACE DIFFERENCE; RETROSPECTIVE STUDY; ADENOCARCINOMA; CLINICAL TRIAL; HOSPITAL; INCIDENCE; MIDDLE AGED; MULTICENTER STUDY; PANCREAS TUMOR; PANCREATECTOMY; SURVIVAL RATE; UNITED STATES; VERY ELDERLY;

ADENOCARCINOMA; AGED; AGED, 80 AND OVER; FEMALE; HOSPITALS; HUMANS; INCIDENCE; MALE; MIDDLE AGED; NEOPLASM STAGING; PANCREATECTOMY; PANCREATIC NEOPLASMS; RETROSPECTIVE STUDIES; SURVIVAL RATE; UNITED STATES;

EID: 85023203945     PISSN: 00034932     EISSN: 15281140     Source Type: Journal    
DOI: 10.1097/SLA.0000000000002404     Document Type: Article

References (28)

1. Rahib L, Smith BD, Aizenberg R, et al. Projecting cancer incidence and deaths to 2030: the unexpected burden of thyroid, liver, and pancreas cancers in the United States. Cancer Res. 2014;74:2913-2921.
2. Siegel RL, Miller KD, Jemal A. Cancer Statistics, 2017. CA Cancer J Clin. 2017;67:7-30.
3. Sener SF, Fremgen A, Menck HR, et al. Pancreatic cancer: a report of treatment and survival trends for 100,313 patients diagnosed from 1985-1995, using the National Cancer Database. J Am Coll Surg. 1999;189:1-7.
4. Riall TS, Nealon WH, Goodwin JS, et al. Pancreatic cancer in the general population: Improvements in survival over the last decade. J Gastrointest Surg. 2006;10:1212-1223. discussion 23-24.
5. Bilimoria KY, Bentrem DJ, Ko CY, et al. National failure to operate on early stage pancreatic cancer. Ann Surg. 2007;246:173-180.
6. Bilimoria KY, Bentrem DJ, Ko CY, et al. Multimodality therapy for pancreatic cancer in the U.S.: utilization, outcomes, and the effect of hospital volume. Cancer. 2007;110:1227-1234.
7. He W, Zhao H, Chan W, et al. Underuse of surgical resection among elderly patients with early-stage pancreatic cancer. Surgery. 2015;158:1226-1234.
8. Strolhl MP, Raigani S, Ammori JB, et al. Surgery for localized pancreatic cancer: the trend is not improving. Pancreas. 2016;45:687-693.
9. King JC, Zenati M, Steve J, et al. Deviations from expected treatment of pancreatic cancer in octogenarians: analysis of patient and surgeon factors. Ann Surg Oncol. 2016;23:4149-4155.
10. Shapiro M, Chen Q, Huang Q, et al. Associations of socioeconomic variables with resection, stage, and survival in patients with early-stage pancreatic cancer. JAMA Surg. 2016;151:338-345.
11. McGhan LJ, Etzioni DA, Gray RJ, et al. Underuse of curative surgery for early stage upper gastrointestinal cancers in the United States. J Surg Res. 2012;177:55-62.
12. Baxter NN, Whitson BA, Tuttle TM. Trends in the treatment and outcome of pancreatic cancer in the United States. Ann Surg Oncol. 2007;14:1320-1326.
13. Swanson RS, Pezzi CM, Mallin K, et al. The 90-day mortality after pancreatectomy for cancer is double the 30-day mortality: more than 20,000 resections from the national cancer data base. Ann Surg Oncol. 2014;21:4059-4067.
14. Lieberman MD, Kilburn H, Lindsey M, et al. Relation of perioperative deaths to hospital volume amont patients undergoing pancreatic resection for malignancy. Ann Surg. 1995;222:638-645.
15. Cloyd JM, Katz MH, Prakash L, et al. Preoperative therapy and pancreatoduodenectomy for pancreatic ductal adenocarcinoma: a 25-year single-institution experience. J Gastrointest Surg. 2017;21:164-174.
16. Picozzi VJ, Oh SY, Edwards A, et al. Five-year actual overall survival in resected pancreatic cancer: a contemporary single-institution experience from a multidisciplinary perspective. Ann Surg Oncol. 2017;24:1722-1730.
17. van Putten M, Verhoeven RH, van Sandick JW, et al. Hospital of diagnosis and probability of having surgical treatment for resectable gastric cancer. Br J Surg. 2016;103:233-241.
18. van Putten M, Koeter M, van Laarhoven HW, et al. Hospital of diagnosis influences the probability of receiving curative treatment for esophageal cancer. Ann Surg. 2016. Epub ahead of print.
19. Boffa DJ, Rosen JE, Mallin K, et al. Using the National Cancer Database for outcomes research: a review. JAMA Oncol. 2017 [Epub ahead of print].
20. American College of Surgeons. National Cancer Database. [cited December 16, 2016]. Available at https://www.facs.org/quality-programs/cancer/ncdb.
21. Deyo RA, Cherkin DC, Ciol MA. Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. Clin Epidemiol. 1992;45: 613-619.
22. Cuzick J. A Wilcoxon-type test for trend. Stat Med. 1985;41:87-90.
23. Mokdad AA, Minter RM, Zhu H, et al. Reply to J. Bergquist et al and T.-Y. Lai et al. J Clin Oncol. 2017;35:1624-1625.
24. Bilimoria KY, Bentrem DJ, Stewart AK, et al. Comparison of commission on cancer-approved and -nonapproved hospitals in the United States: implications for studies that use the National Cancer Data Base. J Clin Oncol. 2009;27:4177-4181.
25. McDowell BD, Chapman CG, Smith BJ, et al. Pancreatectomy predicts improved survival for pancreatic adenocarcinoma: results of an instrumental variable analysis. Ann Surg. 2015;261:740-745.
26. CoC Quality of Care Measures. Available at: https://www.facs.org/qualityprograms/cancer/ncdb/qualitymeasures. Accessed January 15, 2017.
27. NQF Endorses Additional Surgical Measures. Available at: http://www. qualityforum.org/News-And-Resources/Press-Releases/2012/NQF-Endorses-Additional-Surgical-Measures.aspx. Accessed January 15, 2017.
28. Urbach DR. Pledging to eliminate low-volume surgery. N Engl J Med. 2015;373:1385-1388.